Abstract:Interferon-inducible transmembrane (IFITM) proteins are small homologous proteins that are encoded by the interferon-stimulated genes (ISGs), which can be strongly induced by interferon (IFN) and provide resistance to invasion by a variety of viral pathogens. However, the exact molecular mechanisms underlying this function have remained elusive. The antiviral activity of IFITMs from different species depends on S-palmitoylation at conserved cysteine residues. However, specific enzymes involved in the dynamic palmitoylation cycle of IFITMs, especially depalmitoylase, have not yet been reported. Here, we demonstrate that α/-hydrolase domain-containing 16A (ABHD16A) is a depalmitoylase and a negative regulator of IFITM protein that can catalyze the depalmitoyl reaction of S-palmitoylated IFITM proteins, thereby decreasing their antiviral activities on RNA viruses. Using the acyl-PEGyl exchange gel shift (APEGS) assay, we identified ABHD16A proteins from humans, pigs, and mice that can directly participate in the palmitoylation/depalmitoylation cycles of IFITMs in the constructed abhd16a-/- cells and ABHD16A-overexpressing cells. Furthermore, we showed that ABHD16A functions as a regulator of subcellular localization of IFITM proteins and is related to the immune system. It is tempting to suggest that pharmacological intervention in IFITMs and ABHD16A can be achieved either through controlling their expression or regulating their activity, thereby providing a broad-spectrum therapeutic strategy for animal viral diseases. IMPORTANCE IFITM protein is the cells first line of antiviral defense that blocks early stages of viral replication; the underlying mechanism might be associated with the proper distribution in cells. The palmitoylation/depalmitoylation cycle can dynamically regulate protein localization, stability, and function. This work is the first one that found the critical enzyme that participates in the palmitoylation/depalmitoylation cycle of IFITM, and this type of palmitoyl loss may be an essential regulation mode for balancing the antiviral functions of the IFN pathway. These findings imply that the pharmacological intervention in IFITM and ABHD16A, either through controlling their expression or regulating their activities, could provide a broad-spectrum therapeutic strategy for animal viral diseases and complications linked to interferon elevation.

Analgesic domains of interferon-??:

Distinct Domains of IFNalpha Mediate Immune and Analgesic Effects Respectively.

The Analgesic Domain of Interferon-Alpha 2b Contains an Essential Proline(39) Residue

The Analgesic Domain of Interferon-α2b Contains an Essential Proline39 Residue

Distinct structural bases of the immunoregulatory and central analgesic effects of IFNα

Distinct structural bases of the immunoregulatory and central analgesic effects of IFNalpha

Fever of Recombinant Human Interferon-Alpha is Mediated by Opioid Domain Interaction with Opioid Receptor Inducing Prostaglandin E2

The central analgesic effect of interferon-α

Interferon-Alpha Enhances Excitatory Transmission in Substantia Gelatinosa Neurons of Rat Spinal Cord

Interferon-β suppresses inflammatory pain through activating μ-opioid receptor

[Interferon-alpha, beta, gamma]

IFN-τ Alleviates Lipopolysaccharide-Induced Inflammation by Suppressing NF-κB and MAPKs Pathway Activation in Mice

Interleukin-2: Structural and Biological Relatedness to Opioid Peptides

Interferon-Alpha Reinstates Morphine-Conditioned Place Preference Through Opioid Receptors in Rats

Annexin 1 Exerts Anti-Nociceptive Effects after Peripheral Inflammatory Pain Through Formyl-Peptide-receptor-like 1 in Rat Dorsal Root Ganglion

Inquiring into the differential action of interferons (IFNs): an IFN-alpha2 mutant with enhanced affinity to IFNAR1 is functionally similar to IFN-beta

ABHD16A Negatively Regulates the Palmitoylation and Antiviral Function of IFITM Proteins

Analgesic Action of Adenosine A1 Receptor Involves the Dephosphorylation of Glycine Receptor Α1ins Subunit in Spinal Dorsal Horn of Mice.

Site-Specific Lipophilic Modification of Interferon-α

Liver X Receptor A Is Involved In Counteracting Mechanical Allodynia By Inhibiting Neuroinflammation In The Spinal Dorsal Horn

The mechanism of Annexin A1 to modulate TRPV1 and nociception in dorsal root ganglion neurons